Bagdat Akhyt | Medical Devices | Outstanding Scientist Award

Dr. Bagdat Akhyt | Medical Devices | Outstanding Scientist Award

Doctor | JSC “Research Institute of Cardiology and Internal Medicine” | Kazakhstan

Dr. Bagdat Akhyt is a clinical researcher affiliated with JSC “Research Institute of Cardiology and Internal Diseases,” Almaty, Kazakhstan, with expertise in cardiology, cardiac electrophysiology, and advanced device-based therapies. Their research focuses on the management of complex arrhythmias, particularly drug-refractory atrial fibrillation, and outcomes of atrioventricular node ablation combined with cardiac resynchronization therapy defibrillators (CRT-D). Akhyt has authored 2 Scopus-indexed publications, contributing evidence to optimize long-term clinical outcomes in high-risk cardiac patients. Actively collaborating with multidisciplinary and international co-authors, their work supports evidence-based decision-making in cardiovascular care and has potential societal impact by improving quality of life and prognosis for patients with advanced rhythm disorders.

  Publication Metrics (Scopus)

 

   2
   1
   0

Documents

2

Documents

 

View Scopus Profile View ResearchGate Profile

Featured Publication

Ramin Jaberi | Medical Devices | Best Researcher Award

Prof. Dr. Ramin Jaberi | Medical Devices | Best Researcher Award 

Professor | Tehran University of Medical Sciences | Iran

Dr. Ramin Jaberi is a distinguished Medical Physicist specializing in Brachytherapy, Dosimetry, and Monte Carlo Simulation within the field of Radiation Oncology. He earned his Ph.D. in Medical Sciences (2013) from Amsterdam University of Applied Sciences, Netherlands, where he developed a strong foundation in radiation treatment modeling and applied medical physics. Currently serving as a Brachytherapy Physicist at Tehran University of Medical Sciences, Dr. Jaberi brings over two decades of clinical and research experience, contributing extensively to improving cancer radiotherapy accuracy and patient safety. His professional experience includes collaborative projects with prestigious institutions such as the University of Surrey (UK) and participation in IAEA- and ESTRO-supported research initiatives, focusing on optimizing radiation dose distribution and precision therapy. His research interests encompass radiation dose optimization, imaging-based treatment planning, Monte Carlo simulation in radiation transport, and advanced brachytherapy source characterization. Dr. Jaberi’s research skills include expertise in computational modeling, data analysis, radiotherapy system calibration, and experimental dosimetry validation, making him a valuable contributor to the advancement of applied radiation sciences. He has published extensively in Scopus- and IEEE-indexed journals, including numerous Q1-ranked articles addressing clinical and computational aspects of brachytherapy physics. His outstanding academic and clinical contributions have earned him recognition from international medical physics societies and participation in scientific committees and training programs that promote safe radiotherapy practices. A dedicated educator and mentor, he actively supports young researchers in developing computational and analytical approaches to medical physics problems. Dr. Jaberi’s work bridges innovation and clinical application, reflecting a lifelong commitment to enhancing the effectiveness of cancer treatment through research-driven radiotherapy advancements. His consistent scholarly output underscores his impact in biomedical physics, with 385 citations from 337 documents, 56 published papers, and an h-index of 11.

Featured Publications

  1. Naseripour, M., Jaberi, R., Sedaghat, A., Azma, Z., Nojomi, M., Falavarjani, K. G., … (2016). Ruthenium-106 brachytherapy for thick uveal melanoma: Reappraisal of apex and base dose radiation and dose rate. Journal of Contemporary Brachytherapy, 8(1), 66–73.
    Citations: 63

  2. Kalaghchi, B., Esmati, E., Ghalehtaki, R., Gomar, M., Jaberi, R., Gholami, S., … (2018). High-dose-rate brachytherapy in treatment of non-melanoma skin cancer of head and neck region: Preliminary results of a prospective single institution study. Journal of Contemporary Brachytherapy, 10(2), 115–122.
    Citations: 35

  3. Naseripour, M., Maleki, A., Astaraki, A., Sedaghat, A., Jaberi, R., Lee, S., Azma, Z., … (2018). Ruthenium-106 brachytherapy in the treatment of circumscribed choroidal hemangioma. Retina, 38(5), 1024–1030.
    Citations: 32

  4. Allahverdi, M., Sarkhosh, M., Aghili, M., Jaberi, R., Adelnia, A., & Geraily, G. (2012). Evaluation of treatment planning system of brachytherapy according to dose to the rectum delivered. Radiation Protection Dosimetry, 150(3), 312–315.
    Citations: 28

  5. Siavashpour, Z., Aghamiri, M. R., Jaberi, R., Manshadi, H. R. D., & Ghaderi, R. (2016). Optimum organ volume ranges for organs at risk dose in cervical cancer intracavitary brachytherapy. Journal of Contemporary Brachytherapy, 8(2), 135–142.
    Citations: 27